人组织激肽释放酶基因对2型糖尿病大鼠血压的影响及机制

目的：探讨人组织激肽释放酶（HK）基因对2型糖尿病大鼠血压的影响及其机制。方法:高脂高糖饮食加小剂量链脲佐菌素建立2型糖尿病动物模型。以重组腺相关病毒为载体介导HK基因（HK组）或对照基因LacZ（LacZ组）在糖尿病大鼠体内表达，观察实验动物血压变化及离体主动脉对乙酰胆碱（Ach）依赖性血管舒张反应和一氧化氮（NO）、内皮素-1（ET-1）、内皮素受体A（ETA-R）表达。 结果:(1) HK组第2周开始出现血压下降，并一直持续到实验结束（12周时），而LacZ组血压无明显下降。(2) LacZ组离体主动脉对乙酰胆碱（Ach）依赖性血管舒张反应明显低于HK组。(3) HK组大鼠主动脉NO2-/NO3-浓度明显高于LacZ组，而ET-1和ETA-R mRNA明显低于LacZ组。 结论:重组腺相关病毒介导HK基因表达明显降低2型糖尿病大鼠血压，改善内皮依赖性血管舒张功能，原因可能与增加动脉NO释放，减少ET-1和ETA-R的表达有关。

Effect of tissue kallikrein gene treatment on blood pressure in type 2 diabetic rats and its mechanism

AIM:To study the effect of tissue kallikrein gene (HK) treatment on blood pressure in type 2 diabetic rats and its mechanism. METHODS:Male Wistar rats were injected with low dose streptozotocin and fed with diets enriched in fat and sugar to form type 2 diabetic model. Recombinant adeno-associated viral vectors (rAAV)-mediated HK gene (HK group) or LacZ gene (LacZ group) was introduced to the diabetic rats. The systolic blood pressure was measured every 2 weeks. The acetylcholine (Ach)-dependent vasodilation response, the synthesis of nitric oxide (NO), the expression of endothelin-1 (ET-1) and endothelin-A receptor (ETA-R) in the aorta were detected. RESULTS:(1) Systolic blood pressure was significantly higher in diabetic rats than that in normal control rats. In HK group, systolic blood pressure was significantly reduced within 2 weeks after injection with rAAV·HK, reached near normal levels at 4 weeks and kept until the experiments ended (16 weeks). (2) In LacZ group, Ach-dependent vasodilation response of isolated aorta was markedly decreased than that in HK group (P<0.01). (3) The concentration of NO in the aorta of HK group were significantly higher than those in LacZ group. The expression of ET-1 and ETA-R mRNA were significantly decreased in HK group compared with those in LacZ group (P<0.01). CONCLUSION:rAAV-mediated HK gene delivery efficiently lowed blood pressure and attenuated the endothelial function partly through increasing the concentration of NO and inhibiting the expression of ET-1 and ETA-R of aorta in type 2 diabetic rats.